HPV16 constitutes 92.5% of single infections in oropharyngeal squamous cell carcinoma cases
HPV16 Remains the Most Common Type in Throat Cancer
This meta-analysis of 183 studies involving 17,443 patients identifies HPV16 as the predominant genotype in oropharyngeal squamous cell carc…
A large global study of over 17,000 cases shows that HPV16 is the primary driver of most HPV-related throat cancers.
TORS yields oncologic outcomes comparable to radiotherapy in early-stage oropharyngeal cancer
Robotic surgery shows promise as an alternative to radiation therapy
This systematic review of 51 clinical trials found that transoral robotic surgery (TORS) achieves oncologic outcomes comparable to radiother…
Robotic surgery may offer a way to reduce treatment intensity for some patients with throat cancer while maintaining survival rates.
Molecular drivers including DNA damage response and epigenetics contribute to treatment resistance in HPV-positive OPSCC
Understanding the Molecular Causes of Treatment Resistance in Throat Cancer
This systematic review examines the molecular architecture of treatment resistance in patients with HPV-positive oropharyngeal squamous cell…
Doctors are looking into why some throat cancers do not respond to standard treatments like radiation and chemotherapy.
HPV shows strong association with oropharyngeal SCC while other oncogenic viruses show limited evidence
Viruses linked to oral and throat cancers in new review
This systematic review examines the role of various oncogenic viruses in oral and oropharyngeal squamous cell carcinomas. It identifies a co…
A strong link between HPV and throat cancer is confirmed, while other viruses show less clear evidence of causing cancer.
Transitioning from static TNM staging to a multidimensional, adaptive treatment model integrating genomics and immunology for HPV-associated OPSCC
Doctors are shifting from static staging to adaptive care for HPV throat cancer
This narrative review discusses the evolving management of HPV-associated oropharyngeal squamous cell carcinoma. The authors argue for trans…
Medical teams are moving away from old staging rules toward a new model that uses genomics and immunology for precise care.
Oropharyngeal cancer radiotherapy protocols show improved patient-reported outcomes over time
New treatments reduce pain and anxiety for throat cancer patients today
This combined RCT and observational study of 363 Swedish patients with oropharyngeal squamous cell carcinoma compared two treatment protocol…
New throat cancer treatments significantly reduce pain and anxiety while dry mouth persists for many patients
Phase 3 trial compares IMPT versus IMRT plus cisplatin in locally advanced oropharyngeal squamous cell carcinoma
The Pricier Radiation Did Not Beat Standard Radiation for Throat Cancer
This Phase 3 randomized controlled trial enrolled 205 patients with locally advanced oropharyngeal squamous cell carcinoma across 20 UK NHS …
A large UK trial found that precision proton radiation gave similar results to standard X-ray radiation, meaning the older treatment remains…
Research across Head and Neck Cancer
Related studies from across the Head and Neck Cancer family.
Plant extracts like curcumin and resveratrol may inhibit HNSCC growth via specific signaling pathways
Plant extracts may slow growth of head and neck cancer
This systematic review examines the effects of plant extracts, including resveratrol, curcumin, quercetin, and anthocyanins, on head and nec…
Certain plant compounds like curcumin and resveratrol show promise in stopping cancer cell growth and resisting chemotherapy in lab studies.
Submental Artery Island Flap Shows 16% Pooled Locoregional Recurrence in Oral Cavity Reconstruction
Submental artery island flap is a safe option for oral cancer
This meta-analysis pooled data on the submental artery island flap (SAIF) for oral cavity defects after oral squamous cell carcinoma resecti…
A specific surgical technique called the submental artery island flap shows a low recurrence rate for patients with oral cavity defects.
Impact of Perineural Invasion on Survival Outcomes in Oral Squamous Cell Carcinoma
Perineural invasion linked to poorer outcomes in oral squamous cell carcinoma
A meta-analysis of 23,580 patients confirms that perineural invasion is a potent independent predictor of poor survival and high recurrence …
A large review of over 23,000 patients shows that cancer cells spreading along nerves are linked to higher recurrence and lower survival rat…
Cetuximab-based regimens achieve 47% objective response rate in HNSCC after immune checkpoint inhibitor failure
Cetuximab shows activity for head and neck cancer patients
This meta-analysis evaluates cetuximab-based regimens for patients with recurrent or metastatic head and neck squamous cell carcinoma follow…
New data shows cetuximab-based treatments provide meaningful results for head and neck cancer patients after other treatments fail.
AI-based MRI shows 0.82 AUC for detecting cervical lymph node metastases in oral squamous cell carcinoma
AI tools help detect lymph node spread in oral cancer
This meta-analysis of 548 patients evaluates AI-based MRI for detecting cervical lymph node metastases in oral squamous cell carcinoma. The …
Artificial intelligence may help doctors better identify if oral cancer has spread to lymph nodes before surgery.
Immune cell-based therapy shows no significant benefits for tumor response or survival in HNSCC trials
Immune cell therapy shows limited promise for head and neck cancer
This meta-analysis of 30 trials involving 953 patients evaluated immune cell-based therapy (ICT) for head and neck squamous cell carcinoma. …
New data on immune cell-based therapies for head and neck cancer shows mixed results and a need for more rigorous testing.
Perioperative and postoperative immunotherapy timing determines clinical outcomes in locally advanced head and neck squamous cell carcinoma
Timing of immunotherapy affects outcomes for head and neck cancer
This narrative review examines the impact of immunotherapy sequencing on patients with locally advanced head and neck squamous cell carcinom…
The timing of immunotherapy treatment significantly changes how well it controls local and distant spread in head and neck cancer.
Higher preoperative neutrophil-to-lymphocyte ratio predicts poorer survival in oral squamous cell carcinoma patients
High white blood cell ratios predict survival in oral cancer
This meta-analysis of 30 studies indicates that a higher preoperative neutrophil-to-lymphocyte ratio (NLR) is significantly associated with …
A high ratio of neutrophils to lymphocytes before surgery can help doctors predict survival outcomes for patients with oral squamous cell ca…
ALC decline greater than 0.74x10^9/L independently predicts poorer OS and PFS in LA-HNSCC
Lymphocyte Drop During Radiation Tied to Worse Head and Neck Cancer Outcomes
This post-hoc analysis of a phase III trial involved 222 patients with locally advanced head and neck squamous cell carcinoma. The study fou…
A large drop in lymphocytes during radiation for head and neck cancer is linked to poorer survival. This finding may help personalize treatm…
Small bowel metastasis from esophageal squamous cell carcinoma shows male predominance and 6-month median survival
Small bowel spread from esophageal cancer has a short survival window
This systematic review of 23 patients with small bowel metastasis from esophageal squamous cell carcinoma found a strong male predominance (…
Patients with esophageal cancer that spreads to the small bowel often face a short survival window of about 6 months after diagnosis.
Deep Learning algorithms demonstrate potential for diagnosing oral potentially malignant disorders and squamous cell carcinoma
Artificial Intelligence Shows Potential for Detecting Oral Cancer
This meta-analysis evaluated the diagnostic accuracy of deep learning models using white light digital photographs to identify oral malignan…
New research shows that deep learning tools can help identify oral cancer and precancerous conditions using simple digital photos.
PD-1/PD-L1 inhibitors provide superior overall survival compared to chemotherapy or cetuximab in platinum-refractory HNSCC
Newer drugs show better survival for advanced head and neck cancer
This meta-analysis of 5 RCTs involving 1,700 patients found that PD-1/PD-L1 inhibitors resulted in superior overall survival (HR: 0.80) comp…
A review of clinical trials shows that certain immunotherapy drugs offer better survival rates and fewer severe side effects than traditiona…
Questions about Oropharyngeal squamous cell carcinoma
Do modern radiotherapy protocols improve symptoms for those with oropharyngeal squamous cell carcinoma?
Modern radiotherapy protocols for oropharyngeal squamous cell carcinoma have shown improvements in patient-reported outcomes, including fewer symptoms and lower levels of anxiety and depression.
Full answer →What role does HPV play in the development of oropharyngeal squamous cell carcinoma?
HPV, especially type 16, drives most oropharyngeal squamous cell carcinomas through E6/E7 oncoproteins, which disable key tumor suppressors and lead to distinct, often more treatable tumors.
Full answer →